Last updated on November 2019

A Study of Atezolizumab (Anti Pd-L1 Antibody) as Adjuvant Therapy After Definitive Local Therapy in Patients With High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck


Brief description of study

This study will evaluate the efficacy and safety of atezolizumab compared with placebo as adjuvant therapy after definitive local therapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck (SCCHN)

Clinical Study Identifier: NCT03452137

Find a site near you

Start Over

Tygerberg Hospital; Oncology Dept

Cape Town, South Africa
4.51miles
  Connect »

Cancercare Rondebosch Oncology

Cape Town, South Africa
8.12miles
  Connect »

Cape Town Oncology Trials

Cape Town, South Africa
9.6miles
  Connect »